← All trials
NCT05016596
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 31, 2022
- Primary completion
- Feb 28, 2022
- Completion date
- Feb 28, 2022
- First posted
- Aug 23, 2021
- Last posted
- Nov 18, 2021
- Enrollment
- 20
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Wageningen UniversityLead sponsor
- Roquette FreresCollaborator
- Naturex SACollaborator
- Wageningen UniversityReponsible party - principal investigator
- Ingredion IncorporatedCollaborator
- Ingredia S.A.Collaborator
- Winclove Bio Industries BVCollaborator
- Iberica Co. Ltd.Collaborator
- NexiraCollaborator
- WecareCollaborator
- Darling IngredientsCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.